Forbius Is A Clinical Stage Biopharmaceutical Company Founded In 2011With Operations In Austintexasand Originally Based In Montrealcanadathe Company Focuses On Developing Biotherapeutics For Cancer And Fibrotic Diseasesutilizing Protein Engineering To Meet Significant Medical Needsin September 2020Forbius Was Acquired By Bristol Myers Squibbbms Which Integrated Its Tgf Beta Program Into Its Oncology And Fibrosis Pipeline Forbiuskey Product Is Avid200A Phase 1 Ready Tgf Beta Inhibitor Designed To Enhance Immunotherapy Efficacy And Serve As An Anti Fibrotic Therapythe Company Has Collaborated With Canadaae S National Research Council To Advance Its Biotherapeutic Candidatesfollowing The Acquisitionforbiusremaining Assets Were Spun Off Into A Separate Entitywhile Its Legacy Work Continues Under Bms
| Company Name | Formation Biologics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
